{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T23:31:37Z","timestamp":1783207897301,"version":"3.54.6"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"30","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2020,7,23]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MicroRNAs play an important role in the regulation of mRNA translation and have therapeutic potential in cancer and other diseases. To profile the landscape of microRNAs with significant cytotoxicity in the context of glioblastoma (GBM), we performed a high-throughput screen in adult and pediatric GBM cells using a synthetic oligonucleotide library representing all known human microRNAs. Bioinformatics analysis was used to refine this list and the top seven microRNAs were validated in a larger panel of GBM cells using state-of-the-art in vitro assays. The cytotoxic effect of our most relevant candidate was assessed in a preclinical model. Our screen identified ~100 significantly cytotoxic microRNAs with 70% concordance between cell lines. MicroRNA-1300 (miR-1300) was the most potent and robust candidate. We observed a striking binucleated phenotype in miR-1300 transfected cells due to cytokinesis failure followed by apoptosis. This was also observed in two stem-like patient-derived cultures. We identified the physiological role of miR-1300 as a regulator of endomitosis in megakaryocyte differentiation where blockade of cytokinesis is an essential step. In GBM cells, where miR-1300 is normally not expressed, the oncogene Epithelial Cell Transforming 2 (ECT2) was validated as a direct key target. ECT2 siRNA phenocopied the effects of miR-1300, and ECT2 overexpression led to rescue of miR-1300 induced binucleation. We showed that ectopic expression of miR-1300 led to decreased tumor growth in an orthotopic GBM model. Our screen provides a resource for the neuro-oncology community and identified miR-1300 as a novel regulator of endomitosis with translatable potential for therapeutic application.<\/jats:p>","DOI":"10.1038\/s41388-020-1360-y","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T17:09:23Z","timestamp":1592413763000},"page":"5292-5306","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Profiling cytotoxic microRNAs in pediatric and adult glioblastoma cells by high-content screening, identification, and validation of miR-1300"],"prefix":"10.1038","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5241-2520","authenticated-orcid":false,"given":"M.","family":"Boissinot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0937-4554","authenticated-orcid":false,"given":"T. A.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. P.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Polson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Droop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5455-4434","authenticated-orcid":false,"given":"H.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Laslo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. C.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wurdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-2339","authenticated-orcid":false,"given":"S. E.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4423-7256","authenticated-orcid":false,"given":"S. C.","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"1360_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3389\/fgene.2014.00014","volume":"5","author":"K Katsushima","year":"2014","unstructured":"Katsushima K, Kondo Y. Non-coding RNAs as epigenetic regulator of glioma stem-like cell differentiation. Front Genet. 2014;5:14.","journal-title":"Front Genet."},{"key":"1360_CR2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuint.2014.06.002","volume":"77","author":"JV Brower","year":"2014","unstructured":"Brower JV, Clark PA, Lyon W, Kuo JS. MicroRNAs in cancer: glioblastoma and glioblastoma cancer stem cells. Neurochem Int. 2014;77:68\u201377.","journal-title":"Neurochem Int."},{"key":"1360_CR3","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1111\/j.1582-4934.2011.01317.x","volume":"15","author":"J Sana","year":"2011","unstructured":"Sana J, Hajduch M, Michalek J, Vyzula R, Slaby O. MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications. J Cell Mol Med. 2011;15:1636\u201344.","journal-title":"J Cell Mol Med"},{"key":"1360_CR4","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.critrevonc.2017.10.003","volume":"120","author":"BK Ahir","year":"2017","unstructured":"Ahir BK, Ozer H, Engelhard HH, Lakka SS. MicroRNAs in glioblastoma pathogenesis and therapy: a comprehensive review. Crit Rev Oncol Hematol. 2017;120:22\u201333.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1360_CR5","first-page":"7639084","volume":"2017","author":"B Banelli","year":"2017","unstructured":"Banelli B, Forlani A, Allemanni G, Morabito A, Pistillo MP, Romani M. MicroRNA in glioblastoma: an overview. Int J Genom. 2017;2017:7639084.","journal-title":"Int J Genom"},{"key":"1360_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/bs.ircmb.2017.03.002","volume":"333","author":"N Mercatelli","year":"2017","unstructured":"Mercatelli N, Galardi S, Ciafre SA. MicroRNAs as multifaceted players in glioblastoma multiforme. Int Rev Cell Mol Biol. 2017;333:269\u2013323.","journal-title":"Int Rev Cell Mol Biol"},{"key":"1360_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/cdd.2009.71","volume":"17","author":"J Godlewski","year":"2010","unstructured":"Godlewski J, Newton HB, Chiocca EA, Lawler SE. MicroRNAs and glioblastoma; the stem cell connection. Cell Death Differ. 2010;17:221\u20138.","journal-title":"Cell Death Differ"},{"key":"1360_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","volume":"20","author":"J Hayes","year":"2014","unstructured":"Hayes J, Peruzzi PP, Lawler S. MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med. 2014;20:460\u20139.","journal-title":"Trends Mol Med"},{"key":"1360_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrd4359","volume":"13","author":"Z Li","year":"2014","unstructured":"Li Z, Rana TM. Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov. 2014;13:622\u201338.","journal-title":"Nat Rev Drug Discov"},{"key":"1360_CR10","doi-asserted-by":"publisher","first-page":"38628","DOI":"10.18632\/oncotarget.5926","volume":"6","author":"L Chen","year":"2015","unstructured":"Chen L, Kang C. miRNA interventions serve as \u2018magic bullets\u2019 in the reversal of glioblastoma hallmarks. Oncotarget 2015;6:38628\u201342.","journal-title":"Oncotarget"},{"key":"1360_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08390-z","volume":"10","author":"V Bhaskaran","year":"2019","unstructured":"Bhaskaran V, Nowicki MO, Idriss M, Jimenez MA, Lugli G, Hayes JL, et al. The functional synergism of microRNA clustering provides therapeutically relevant epigenetic interference in glioblastoma. Nat Commun. 2019;10:442.","journal-title":"Nat Commun."},{"key":"1360_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s13311-018-00702-3","volume":"16","author":"AM Krichevsky","year":"2019","unstructured":"Krichevsky AM, Uhlmann EJ. Oligonucleotide therapeutics as a new class of drugs for malignant brain tumors: targeting mRNAs, regulatory rnas, mutations, combinations, and beyond. Neurotherapeutics. 2019;16:319\u201347.","journal-title":"Neurotherapeutics"},{"key":"1360_CR13","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/jcm4081612","volume":"4","author":"VC LeBlanc","year":"2015","unstructured":"LeBlanc VC, Morin P. Exploring miRNA-associated signatures with diagnostic relevance in glioblastoma multiforme and breast cancer patients. J Clin Med. 2015;4:1612\u201330.","journal-title":"J Clin Med"},{"key":"1360_CR14","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nrneurol.2015.171","volume":"11","author":"M Westphal","year":"2015","unstructured":"Westphal M, Lamszus K. Circulating biomarkers for gliomas. Nat Rev Neurol. 2015;11:556\u201366.","journal-title":"Nat Rev Neurol"},{"key":"1360_CR15","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1158\/1541-7786.MCR-14-0268","volume":"12","author":"P Moskwa","year":"2014","unstructured":"Moskwa P, Zinn PO, Choi YE, Shukla SA, Fendler W, Chen CC, et al. A functional screen identifies miRs that induce radioresistance in glioblastomas. Mol Cancer Res. 2014;12:1767\u201378.","journal-title":"Mol Cancer Res"},{"key":"1360_CR16","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1177\/1087057115578837","volume":"20","author":"A Eulalio","year":"2015","unstructured":"Eulalio A, Mano M. MicroRNA screening and the quest for biologically relevant targets. J Biomol Screen. 2015;20:1003\u201317.","journal-title":"J Biomol Screen"},{"key":"1360_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1083\/jcb.201204107","volume":"198","author":"RN Bastos","year":"2012","unstructured":"Bastos RN, Penate X, Bates M, Hammond D, Barr FA. CYK4 inhibits Rac1-dependent PAK1 and ARHGEF7 effector pathways during cytokinesis. The J Cell Biol. 2012;198:865\u201380.","journal-title":"J Cell Biol"},{"key":"1360_CR18","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.devcel.2011.11.003","volume":"21","author":"KC Su","year":"2011","unstructured":"Su KC, Takaki T, Petronczki M. Targeting of the RhoGEF Ect2 to the equatorial membrane controls cleavage furrow formation during cytokinesis. Dev Cell. 2011;21:1104\u201315.","journal-title":"Dev Cell."},{"key":"1360_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.devcel.2011.12.019","volume":"22","author":"Y Gao","year":"2012","unstructured":"Gao Y, Smith E, Ker E, Campbell P, Cheng EC, Zou S, et al. Role of RhoA-specific guanine exchange factors in regulation of endomitosis in megakaryocytes. Dev Cell. 2012;22:573\u201384.","journal-title":"Dev Cell."},{"key":"1360_CR20","doi-asserted-by":"publisher","first-page":"D109","DOI":"10.1093\/nar\/gkh023","volume":"32","author":"S Griffiths-Jones","year":"2004","unstructured":"Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res. 2004;32:D109\u201311.","journal-title":"Nucleic Acids Res."},{"key":"1360_CR21","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gkj112","volume":"34","author":"S Griffiths-Jones","year":"2006","unstructured":"Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34:D140\u20134.","journal-title":"Nucleic Acids Res."},{"key":"1360_CR22","doi-asserted-by":"publisher","first-page":"D154","DOI":"10.1093\/nar\/gkm952","volume":"36","author":"S Griffiths-Jones","year":"2008","unstructured":"Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008;36:D154\u20138.","journal-title":"Nucleic Acids Res"},{"key":"1360_CR23","doi-asserted-by":"publisher","first-page":"D152","DOI":"10.1093\/nar\/gkq1027","volume":"39","author":"A Kozomara","year":"2011","unstructured":"Kozomara A, Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011;39:D152\u20137.","journal-title":"Nucleic Acids Res"},{"key":"1360_CR24","doi-asserted-by":"publisher","first-page":"D68","DOI":"10.1093\/nar\/gkt1181","volume":"42","author":"A Kozomara","year":"2014","unstructured":"Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68\u201373.","journal-title":"Nucleic Acids Res."},{"key":"1360_CR25","doi-asserted-by":"publisher","first-page":"e05005.","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005.","journal-title":"eLife"},{"key":"1360_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92\u2013105.","journal-title":"Genome Res."},{"key":"1360_CR27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/nsmb.2115","volume":"18","author":"DM Garcia","year":"2011","unstructured":"Garcia DM, Baek D, Shin C, Bell GW, Grimson A, Bartel DP. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat Struct Mol Biol. 2011;18:1139\u201346.","journal-title":"Nat Struct Mol Biol"},{"key":"1360_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","volume":"27","author":"A Grimson","year":"2007","unstructured":"Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27:91\u2013105.","journal-title":"Mol Cell."},{"key":"1360_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15\u201320.","journal-title":"Cell."},{"key":"1360_CR30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.molcel.2014.02.013","volume":"53","author":"JW Nam","year":"2014","unstructured":"Nam JW, Rissland OS, Koppstein D, Abreu-Goodger C, Jan CH, Agarwal V, et al. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol Cell. 2014;53:1031\u201343.","journal-title":"Mol Cell."},{"key":"1360_CR31","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2010.06.005","volume":"38","author":"C Shin","year":"2010","unstructured":"Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, Bartel DP. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell. 2010;38:789\u2013802.","journal-title":"Mol Cell."},{"key":"1360_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.stem.2009.11.002","volume":"6","author":"H Wurdak","year":"2010","unstructured":"Wurdak H, Zhu S, Romero A, Lorger M, Watson J, Chiang CY, et al. An RNAi screen identifies TRRAP as a regulator of brain tumor-initiating cell differentiation. Cell Stem Cell. 2010;6:37\u201347.","journal-title":"Cell Stem Cell"},{"key":"1360_CR33","doi-asserted-by":"publisher","first-page":"eear2718.","DOI":"10.1126\/scitranslmed.aar2718","volume":"10","author":"ES Polson","year":"2018","unstructured":"Polson ES, Kuchler VB, Abbosh C, Ross EM, Mathew RK, Beard HA, et al. KHS101 disrupts energy metabolism in human glioblastoma cells and reduces tumor growth in mice. Sci Transl Med. 2018;10:eear2718.","journal-title":"Sci Transl Med"},{"key":"1360_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/bioinformatics\/btn615","volume":"25","author":"S Carbon","year":"2009","unstructured":"Carbon S, Ireland A, Mungall CJ, Shu S, Marshall B, Lewis S, et al. AmiGO: online access to ontology and annotation data. Bioinformatics.2009;25:288\u20139.","journal-title":"Bioinformatics"},{"key":"1360_CR35","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.advenzreg.2009.10.010","volume":"50","author":"AP Fields","year":"2010","unstructured":"Fields AP, Justilien V. The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer. Adv Enzym Regul. 2010;50:190\u2013200.","journal-title":"Adv Enzym Regul"},{"key":"1360_CR36","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1158\/1541-7786.MCR-11-0616","volume":"10","author":"SP Fortin","year":"2012","unstructured":"Fortin SP, Ennis MJ, Schumacher CA, Zylstra-Diegel CR, Williams BO, Ross JT, et al. Cdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cells. Mol Cancer Res. 2012;10:958\u201368.","journal-title":"Mol Cancer Res"},{"key":"1360_CR37","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.2353\/ajpath.2008.080043","volume":"173","author":"B Salhia","year":"2008","unstructured":"Salhia B, Tran NL, Chan A, Wolf A, Nakada M, Rutka F, et al. The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol. 2008;173:1828\u201338.","journal-title":"Am J Pathol"},{"key":"1360_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4419-6199-0_3","volume":"676","author":"G Normand","year":"2010","unstructured":"Normand G, King RW. Understanding cytokinesis failure. Adv Exp Med Biol. 2010;676:27\u201355.","journal-title":"Adv Exp Med Biol"},{"key":"1360_CR39","first-page":"1093","volume":"16","author":"M Sano","year":"2006","unstructured":"Sano M, Genkai N, Yajima N, Tsuchiya N, Homma J, Tanaka R, et al. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep. 2006;16:1093\u20138.","journal-title":"Oncol Rep."},{"key":"1360_CR40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nchembio.363","volume":"6","author":"AB Castoreno","year":"2010","unstructured":"Castoreno AB, Smurnyy Y, Torres AD, Vokes MS, Jones TR, Carpenter AE, et al. Small molecules discovered in a pathway screen target the Rho pathway in cytokinesis. Nat Chem Biol. 2010;6:457\u201363.","journal-title":"Nat Chem Biol"},{"key":"1360_CR41","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1242\/jcs.03032","volume":"119","author":"RB Chalamalasetty","year":"2006","unstructured":"Chalamalasetty RB, Hummer S, Nigg EA, Sillje HH. Influence of human Ect2 depletion and overexpression on cleavage furrow formation and abscission. J Cell Sci. 2006;119:3008\u201319.","journal-title":"J Cell Sci"},{"key":"1360_CR42","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1182\/blood-2010-09-299719","volume":"117","author":"S Nagalla","year":"2011","unstructured":"Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, et al. Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood. 2011;117:5189\u201397.","journal-title":"Blood."},{"key":"1360_CR43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.cell.2012.06.032","volume":"150","author":"Q Wen","year":"2012","unstructured":"Wen Q, Goldenson B, Silver SJ, Schenone M, Dancik V, Huang Z, et al. Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL. Cell. 2012;150:575\u201389.","journal-title":"Cell."},{"key":"1360_CR44","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1182\/blood-2004-10-3934","volume":"105","author":"BJ Lannutti","year":"2005","unstructured":"Lannutti BJ, Blake N, Gandhi MJ, Reems JA, Drachman JG. Induction of polyploidization in leukemic cell lines and primary bone marrow by Src kinase inhibitor SU6656. Blood. 2005;105:3875\u20138.","journal-title":"Blood."},{"key":"1360_CR45","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nature05349","volume":"444","author":"SG Piccirillo","year":"2006","unstructured":"Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature. 2006;444:761\u20135.","journal-title":"Nature."},{"key":"1360_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cell.2014.02.030","volume":"157","author":"ML Suva","year":"2014","unstructured":"Suva ML, Rheinbay E, Gillespie SM, Patel AP, Wakimoto H, Rabkin SD, et al. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells. Cell. 2014;157:580\u201394.","journal-title":"Cell."},{"key":"1360_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.stemcr.2016.12.005","volume":"8","author":"HO King","year":"2017","unstructured":"King HO, Brend T, Payne HL, Wright A, Ward TA, Patel K, et al. RAD51 is a selective DNA repair target to radiosensitize glioma stem cells. Stem Cell Rep. 2017;8:125\u201339.","journal-title":"Stem Cell Rep"},{"key":"1360_CR48","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1200\/JCO.2017.73.0119","volume":"35","author":"BM Alexander","year":"2017","unstructured":"Alexander BM, Cloughesy TF. Adult glioblastoma. J Clin Oncol. 2017;35:2402\u20139.","journal-title":"J Clin Oncol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-1360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-1360-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-1360-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T15:09:33Z","timestamp":1650208173000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-020-1360-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":48,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2020,7,23]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1038\/s41388-020-1360-y","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"29 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}